Año: 2000
Journal Impact Factor (JIF): 8,018
| Categoría | Edición | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|---|
| IMMUNOLOGY | SCIE | 7/116 | Q1 | T1 | D1 |
| INFECTIOUS DISEASES | SCIE | 1/36 | Q1 | T1 | D1 |
| VIROLOGY | SCIE | 1/28 | Q1 | T1 | D1 |
Año: 2017
Journal Citation Indicator (JCI): 1,370
| Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
|---|---|---|---|---|---|
| IMMUNOLOGY | 24/173 | Q1 | T1 | D2 | 86,42 |
| INFECTIOUS DISEASES | 11/111 | Q1 | T1 | D1 | 90,54 |
| VIROLOGY | 5/39 | Q1 | T1 | D2 | 88,46 |
Año:
2011
CiteScore:
11,900
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| General Medicine | 134/3161 | Q1 | T1 | D1 |
| Immunology and Allergy | 14/155 | Q1 | T1 | D1 |
| Infectious Diseases | 9/220 | Q1 | T1 | D1 |
| Immunology | 18/170 | Q1 | T1 | D2 |
SJR año:
2000
Factor de Impacto:
3,611
| Categoría | Posición | Cuartil | Tercil | Decil |
|---|---|---|---|---|
| Immunology | 14/153 | Q1 | T1 | D1 |
| Immunology and Allergy | 10/125 | Q1 | T1 | D1 |
| Infectious Diseases | 3/133 | Q1 | T1 | D1 |
| # | Autor | Afiliación |
|---|---|---|
| 1 | Puig, T | Sin datos () |
| 2 | Perez-Olmeda, M | Hospital Carlos Iii (Spain) |
| 3 | Rubio, A | Hospital Universitario Virgen del Rocío (Spain) |
| 4 | Hospital Universitari Germans Trias i Pujol (Spain) | |
| 5 | Briones, C | Hospital Carlos Iii (Spain) |
| 6 | Franco, JM | Hospital Universitario Virgen del Rocío (Spain) |
| 7 | Gomez-Cano, M | Hospital Carlos Iii (Spain) |
| 8 | Stuyver, L | Innogenetics (Belgium) |
| 9 | Zamora, L | Universidad Autónoma de Madrid, Facultad de Medicina (Spain) |
| 10 | Alvarez, C | Universidad Autónoma de Madrid, Facultad de Medicina (Spain) |
| 11 | Leal, M | Hospital Universitario Virgen del Rocío (Spain) |
| 12 | Clotet, B | Sin datos () |
| 13 | Soriano, V | Hospital Carlos Iii (Spain) |
| # | Autoría grupal | Afiliación |
| 1 | Pedreira, J. (The ERASE-2 Study Group) | Sin datos () |
| 2 | Cartón, A.J. (The ERASE-2 Study Group) | Sin datos () |
| 3 | Echevarria, S. (The ERASE-2 Study Group) | Sin datos () |
| 4 | Iribarren, J.A. (The ERASE-2 Study Group) | Sin datos () |
| 5 | Cuesta, J. (The ERASE-2 Study Group) | Sin datos () |
| 6 | Solá, J. (The ERASE-2 Study Group) | Sin datos () |
| 7 | Del Pozo, M.A. (The ERASE-2 Study Group) | Sin datos () |
| 8 | Alvarez, L. (The ERASE-2 Study Group) | Sin datos () |
| 9 | Rubio, R., Gatel, J. (The ERASE-2 Study Group) | Sin datos () |
| 10 | Alcácer, F. (The ERASE-2 Study Group) | Sin datos () |
| 11 | González-Lahoz, J. (The ERASE-2 Study Group) | Sin datos () |
| 12 | Portilla, J.(The ERASE-2 Study Group) | Sin datos () |
| 13 | Villalonga, C. (The ERASE-2 Study Group) | Sin datos () |
| 14 | Moreno, S. (The ERASE-2 Study Group) | Sin datos () |
| 15 | Kidelan, J.M. (The ERASE-2 Study Group) | Sin datos () |
| 16 | Marquez, M. (The ERASE-2 Study Group) | Sin datos () |
| 17 | Muǹ, A. (The ERASE-2 Study Group) | Sin datos () |
